Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.6 USD | -5.74% | -7.69% | -25.12% |
Apr. 01 | Wells Fargo Cuts Affimed Price Target to $25 From $30, Maintains Overweight Rating | MT |
Apr. 01 | HC Wainwright Adjusts Affimed's Price Target to $10 From $50, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.12% | 74.31M | |
-2.11% | 104B | |
+1.63% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-16.95% | 15.06B | |
+3.77% | 13.98B | |
+33.78% | 11.66B |
- Stock Market
- Equities
- AFMD Stock
- News Affimed N.V.
- Affimed Starts Patient Enrolment for Study to Evaluate Combination Treatment Targeting Solid Tumors -- Shares Rise in Pre-Market